Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Sharing Decision-making Program for HCC Patients Treatment Decisions [NA]
A completed clinical trial evaluating a Shared Decision-Making Program for treatment decisions in patients with hepatocellular cancer.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC [Phase 1, Phase 2]
Early-phase trial investigating sintilimab plus a bevacizumab biosimilar for potentially resectable intermediate hepatocellular carcinoma (P…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer [Phase 2]
Phase 2 trial evaluating CS1008 in combination with sorafenib versus sorafenib alone in advanced liver cancer has completed recruitment with…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 trial of refametinib in RAS mutant hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating E7050 plus sorafenib versus sorafenib alone as first-line therapy in hepatocellular carcinoma has completed, wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Tislelizumab Combined With Lenvatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating tislelizumab in combination with lenvatinib as perioperative therapy for resectable hepatocellular carcinoma; statu…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC) [Phase 2]
A Phase 2 trial evaluating refametinib in combination with sorafenib in RAS-mutant hepatocellular carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer [Phase 1, Phase 2]
Phase 1/2 study of sacituzumab govitecan-hziy (IMMU-132) in adults with epithelial cancers; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs). [Phase 2]
Phase 2 study evaluating camrelizumab combined with apatinib in hepatocellular carcinoma patients previously treated with immune checkpoint …
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC
Prospective study assessing safety of Deb-TACE with 100µ beads in patients with non-resectable hepatocellular carcinoma; completed with post…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer [Phase 2]
Phase 2 trial update on T cell receptor immunotherapy targeting NY-ESO-1 in NY-ESO-1 expressing cancers; study is completed with results pos…
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01) [Phase 2, Phase 3]
Clinical trial update on combining sintilimab with stereotactic body radiotherapy (SBRT) in hepatocellular carcinoma (HCC) across Phase 2 an…
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Transarterial Embolization Alone Versus Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma [Phase 3]
Phase 3 trial comparing transarterial embolization alone to drug-eluting beads chemoembolization for hepatocellular carcinoma is in progress…
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment [Phase 2]
Phase II trial of avelumab in advanced hepatocellular carcinoma after prior sorafenib treatment has been completed.
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Thermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC [Phase 3]
Phase 3 trial evaluating thermal ablation combined with anlotinib and TQB2450 (PD-L1 inhibitor) for hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma [Phase 2, Phase 3]
Phase 2/3 trial evaluating microwave ablation combined with cellular immunotherapy for hepatocellular carcinoma completed.
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Sintilimab Combined With Lenvatinib in Local Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating sintilimab plus lenvatinib in locally advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy [NA]
Pilot study assessing theragnostically planned liver radiation to optimize radiation therapy for liver cancer, completed with posted results…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Study to Evaluate VORTX Rx (Theresa) [NA]
Completed clinical trial update for VORTX Rx (Theresa) evaluating hepatocellular carcinoma with liver metastases; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis [Phase 2]
Phase 2 trial update evaluating systemic chemotherapy plus lenvatinib and toripalimab for hepatocellular carcinoma with extrahepatic metasta…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging [Phase 2]
Phase 2 trial investigating hypoxic changes in hepatocellular carcinoma after transarterial chemoembolization and stereotactic radiation usi…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma [Phase 3]
Phase 3 trial evaluating DEB-TACE in combination with lenvatinib, sorafenib, or a PD-1 inhibitor for unresectable hepatocellular carcinoma i…
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 study evaluating HX008 in combination with bevacizumab or lenvatinib for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies [Phase 1, Phase 2]
Clinical trial update on autologous CAR-T/TCR-T cell therapy for solid malignancies across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies [EARLY_Phase 1]
Early phase1 trial evaluating vandetanib-eluting radiopaque embolic beads for resectable liver malignancies has completed with results poste…